Furthermore, in contrast to healthy controls and patients with Alzheimer’s disease, MS patients specifically produce autoantibodies to the non-myelin antigen heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) [22–27]. This evidence concerns the gene HNRNPA1 and myeloid sarcoma.